NRG Oncology Assessment of Artificial Intelligence Deep Learning–Based Auto-segmentation for Radiation Therapy: Current Developments, Clinical Considerations, and Future Directions
International Journal of Radiation Oncology*Biology*Physics · 2024-05 · 119 (1) · 261-280
DOI: 10.1016/j.ijrobp.2023.10.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-05. Verfasst von Yi Rong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona. Electronic address: rong.yi@mayo.edu. Hauptthemen laut MEDLINE: Deep Learning, Radiation Oncology. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Deep learning neural networks (DLNN) in Artificial intelligence (AI) have been extensively explored for automatic segmentation in radiotherapy (RT). In contrast to traditional model-based methods, data-driven AI-based models for auto-segmentation have shown high accuracy in early studies in research settings and controlled environment (single institution). Vendor-provided commercial AI models are made available as part of the integrated treatment planning system (TPS) or as a stand-alone tool that provides streamlined workflow interacting with the main TPS. These commercial tools have drawn clinics' attention thanks to their significant benefit in reducing the workload from manual contouring and shortening the duration of treatment planning. However, challenges occur when applying these commercial AI-based segmentation models to diverse clinical scenarios, particularly in uncontrolled environments. Contouring nomenclature and guideline standardization has been the main task undertaken by the NRG Oncology. AI auto-segmentation holds the potential clinical trial participants to reduce interobserver variations, nomenclature non-compliance, and contouring guideline deviations. Meanwhile, trial reviewers could use AI tools to verify contour accuracy and compliance of those submitted datasets. In recognizing the growing clinical utilization and potential of these commercial AI auto-segmentation tools, NRG Oncology has formed a working group to evaluate the clinical utilization and potential of commercial AI auto-segmentation tools. The group will assess in-house and commercially available AI models, evaluation metrics, clinical challenges, and limitations, as well as future developments in addressing these challenges. General recommendations are made in terms of the implementation of these commercial AI models, as well as precautions in recognizing the challenges and limitations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona. Electronic address: rong.yi@mayo.edu.
- Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Commack, New York.
- Department of Radiation Oncology, Emory University, Atlanta, Georgia.
- Department of Radiation Oncology, University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
- Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Rong, Y., Chen, Q., Fu, Y., Yang, X., Al-Hallaq, H. A., Wu, Q. J., Yuan, L., Xiao, Y., Cai, B., Latifi, K., Benedict, S. H., Buchsbaum, J. C., & Qi, X. S. (2024). NRG Oncology Assessment of Artificial Intelligence Deep Learning–Based Auto-segmentation for Radiation Therapy: Current Developments, Clinical Considerations, and Future Directions. International Journal of Radiation Oncology*Biology*Physics, 119(1), 261-280. https://doi.org/10.1016/j.ijrobp.2023.10.033
Vancouver
Rong Y, Chen Q, Fu Y, Yang X, Al-Hallaq HA, Wu QJ, et al. NRG Oncology Assessment of Artificial Intelligence Deep Learning–Based Auto-segmentation for Radiation Therapy: Current Developments, Clinical Considerations, and Future Directions. International Journal of Radiation Oncology*Biology*Physics. 2024;119(1):261-280. doi:10.1016/j.ijrobp.2023.10.033
BibTeX
@article{Rong2024,
author = {Rong, Yi and Chen, Quan and Fu, Yabo and Yang, Xiaofeng and Al-Hallaq, Hania A and Wu, Q Jackie and Yuan, Lulin and Xiao, Ying and Cai, Bin and Latifi, Kujtim and Benedict, Stanley H and Buchsbaum, Jeffrey C and Qi, X Sharon},
title = {NRG Oncology Assessment of Artificial Intelligence Deep Learning–Based Auto-segmentation for Radiation Therapy: Current Developments, Clinical Considerations, and Future Directions},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {119},
number = {1},
pages = {261--280},
doi = {10.1016/j.ijrobp.2023.10.033}
}
EUVIMED